Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Someone asked wotton that and he said he is in no hurry to convert at these levels. So my guess is they won't sell shares without an institutional investor sponsor.
Yahoo news has a spotlight feed 10q on actc for Nov 13. It's a dead link but I'm thinking we see it tomorrow.
Ok Crawford I concede. I wanted a new proxy but the people have spoken. I will now reach hands across the aisle and strive to bring positive insights to this board.
Great article thanks andy
Wow price is hanging in there lots of sells
Uplist was delayed might see 6
Must have passed it's nose diving
Wonder when we see the next proxy
Haha guy
Yeah I hate to trade within 3 days of my buy but I have to trade out heading into dilution of 60%. If alpha thinks that's good alpha can have it.
As soon as my actc deficit is released I will vote yes
Actc mentioned as hidden breakout in bankruptcies breakouts and busts what's happening in biotech. Check yahoo feed news
Looks like share package for jooste le reux in the works 11/14 ot 17
Hopefully we stay above 6. Market seems to think proxy will pass
For the execs to know an institutional investor was there and was going to ask a question is strange. He was either invited or he was set up to deliver an arrow across the bow of the short boat...
Oh I'm sure big pharma is here this stock is doing exactly what all big runners do. Go down unexplainably
Eyelia? Hope they didn't pay their chief marketing officer cmo 30 million shares for that snappy name
Tenthoff asked how many patients in phase 2... as if to calculate how much money they will need ... as if to plan a target price...?
Tenthoff dang autocorrect
Ask Ted (edward) tentoff that question he is with piper jaffray since 2003 asked the question of how many patients in p2 trial... he called regeneron at 14 dollars.
Yeah even the 10 q is ominously silent
Aye eye that's a good point but the part of this which is really sad to me is we have a group of scientists curing diseases and we just can't get money to roll it forward. This should be backed with resources by now.
That's not fair fuller the phase 1 study shows us proof. But it was funny. Ouch
Regarding item 4 the 10 q the mmd trial initiated June 2014 but had potential issues with patient safety requiring a delay in enrollment.
Nice to have u here.
Probably a good move. I see u reentering at 6.15 if the proxy passes but u will miss the gap up if it fails
Trying to keep up w dilution
I don't see in increase in share price coming until Lincoln stops dumping and investors see a reason to jump in. Probably be 9 months. Might take a little off the table here
We are starting to correct
For those that don't know there were links posted that actc met w jeffries market maker symbol jeff Oct 28 and 29 and 30. If u know jeff they are Notorious for naked shorting otc issues. They were caught by attorney bill Frizzell according to the court docket short over 100 million shares of a mining stock cmkx. U can confirm this by Google cmkx the jeffries letter. Please do not allow our company to let naked shorts off the hook thru dilution. If u have voted change your vote to no its not too late. Don't let big pharma ceo and v.p. do a number 2 on us it's not ethical.
I'm in it for the sport. No money is enough for this treasure
Not me. No chance.
We could go alone if they give up their salaries
Even a blind squirrel gets an acorn once in a while
It will do that and more. But there still is a right and wrong way to treat phase I investors
A respectful person can accomplish anything. Greed makes the experienced falter
It happens
Teehee I'm negotiating